Perphenazine

奋乃静

Report date: 2026/03/17 20:00:15
NME

Base Information

Drug NamePerphenazine
Drug Alias Name奋乃近羟哌氯丙嗪10γ羟乙基哌嗪丙基2氯代吩噻嗪佩吩嗪Fentazin +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor antagonists
TargetsDopamine D2 receptor
Therapy Area/IndicationsSchizophreniaVomitingNausea +[4] 
Global Approved IndicationsSchizophreniaVomitingNausea +[4] 
Approved Indications in ChinaSchizophreniaVomiting
Original Approved Country/TerritoryUnited States
Original Approved Date1957/02/27
Country/TerritoryUnited StatesMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesMitsubishi Tanabe PharmaTianjin Lisheng Pharmaceutical Co Ltd
Inactive CompaniesSchering Ag
Active IndicationsSchizophreniaVomitingNausea +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN05AB03
Related LinksWikipediaDrugBankKEGG